-
Laronidase
- indication:For the treatment of mucopolysaccharidosis
- pharmacologypharmacology:
- mechanism: Laronidase catalyses the hydrolysis of terminal alpha-L-iduronic acid residues of dermatan sulfate and heparin sulfate.
- toxicity:
- absorprion:
- halflife: 1.5-3.6 hrs
- roouteelimination:
- volumedistribution:
- clearance: